or Try an Advanced Search...

    Technical Analysis for FBIOP - Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

    Grade Last Price % Change Price Change
    F 5.25 1.94% 0.10
    FBIOP closed down 0.36 percent on Wednesday, November 20, 2024, on 61 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical FBIOP trend table...
    Date Alert Name Type % Chg
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.94%
    Spinning Top Other 1.94%
    NR7 Range Contraction 1.94%
    Narrow Range Bar Range Contraction 1.94%
    Inside Day Range Contraction 1.94%
    Oversold Stochastic Weakness 1.94%
    20 DMA Resistance Bearish 1.57%
    50 DMA Resistance Bearish 1.57%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.57%
    Stochastic Buy Signal Bullish 1.57%
    Older End-of-Day Signals for FBIOP ...

       Recent Intraday Alerts

    Alert Time
    Rose Above 10 DMA about 2 hours ago
    Up 1% about 2 hours ago
    10 DMA Resistance 1 day ago
    Up 1% 1 day ago
    Possible Pocket Pivot 2 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    FBIOP Chart by TradingView
    Basic chart:

    Profile

    Fortress Biotech Inc is a biopharmaceutical company. The Company is engaged in the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Cancer Clinical Medicine Life Sciences Immunotherapy Autoimmune Disease Virotherapy Treatment Of Autoimmune Disease

    Is FBIOP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 14 Fortress Biotech: Q3 Earnings Snapshot
    Nov 14 Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
    Nov 14 Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
    Nov 12 Checkpoint Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Updates
    Nov 12 Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
    Nov 12 Mustang Bio Receives Positive Listing Determination from Nasdaq
    Nov 4 Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea
    Oct 31 Fortress Biotech Insiders Placed Bullish Bets Worth US$4.49m
    Oct 25 Highbridge Capital Management's Strategic Acquisition of Fortress Biotech Shares
    Oct 25 Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference
    See more FBIOP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 17.473
    52 Week Low 4.86
    Average Volume 19,391
    200-Day Moving Average 11.04
    50-Day Moving Average 5.41
    20-Day Moving Average 5.45
    10-Day Moving Average 5.16
    Average True Range 0.38
    RSI (14) 41.18
    ADX 16.89
    +DI 19.82
    -DI 16.20
    Chandelier Exit (Long, 3 ATRs) 5.57
    Chandelier Exit (Short, 3 ATRs) 6.14
    Upper Bollinger Bands 6.17
    Lower Bollinger Band 4.73
    Percent B (%b) 0.29
    BandWidth 26.34
    MACD Line -0.14
    MACD Signal Line -0.11
    MACD Histogram -0.0269
    Fundamentals Value
    Market Cap 291.9 Million
    Num Shares 56.7 Million
    EPS -0.86
    Price-to-Earnings (P/E) Ratio -5.97
    Price-to-Sales 1.20
    Price-to-Book 0.00
    Dividend 0.00
    Dividend Yield 0.00%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.38
    Resistance 3 (R3) 5.38 5.32 5.34
    Resistance 2 (R2) 5.32 5.26 5.31 5.32
    Resistance 1 (R1) 5.23 5.22 5.20 5.23 5.31
    Pivot Point 5.17 5.17 5.15 5.16 5.17
    Support 1 (S1) 5.08 5.11 5.05 5.08 4.99
    Support 2 (S2) 5.02 5.07 5.01 4.98
    Support 3 (S3) 4.93 5.02 4.96
    Support 4 (S4) 4.93